The judge ruled the "unjust enrichment" suit failed to even plausibly allege the "enrichment" of Abbott Labs — let alone the ...
Until the U.S. addresses the extreme concentration in the infant formula industry, the country is just one plant closure away ...
Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. The company received a groundbreaking FDA approval for its latest drug-eluting scaffold ...
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee. The device, called the Esprit BTK System, is meant to treat patients who ...
Abbott (NYSE:ABT) said it has received FDA approval for its Esprit BTK dissolvable stent for the treatment of blocked arteries below the knee. The Esprit BTK System is aimed at keeping arteries ...
April 29, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System ...
Robert Ford told investors the cases will start this summer, adding that "they're really seeking to advance a theory promoted ...
April 29, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit ...